20/20 BioLabs reports Q2 revenue growth, outlines Medicare strategy

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/2/2026

1. PANW
2. GTLB
3. DELL
4. MDB
5. GOOGL
6. VRTS
7. SPY
8. HPE
9. USO
10. SNOW

Go back to 20/20 BioLabs reports Q2 revenue growth, outlines Medicare strategy
(NASDAQ: AIDX) Delayed: 0.63 +0.01 (1.61%)
Previous Close $0.62    52 Week High $ 
Open $0.65    52 Week Low $ 
Day High $0.68    P/E N/A 
Day Low $0.61    EPS $ 
Volume 122,495